NCT01722058View on ClinicalTrials.gov

A Phase I In-Vivo Peptide Applied in the Right Colon

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions
Colon Lesions
Interventions
DRUG

Peptide application

Trial Locations (1)

48103

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT01722058 - A Phase I In-Vivo Peptide Applied in the Right Colon | Biotech Hunter | Biotech Hunter